InvestorsHub Logo
Followers 6
Posts 2155
Boards Moderated 0
Alias Born 11/26/2014

Re: None

Thursday, 12/14/2017 2:04:37 PM

Thursday, December 14, 2017 2:04:37 PM

Post# of 38634
All- I really think what we are seeing with the price action is uncertainty about another offering. Let's face it- MNK just did not deliver getting Seroquel contracts early and sales numbers are bad until they can claim some of these contracts. So What I think people are worried about is another offering early or mid next year. A couple things that could help alleviate some of this anxiety:

1. Markedly improved Seroquel numbers. I am getting the impression this is a few months out though.
2. Cash infusion from partnership.
3. Approval of Pristiq or Lamictal. These could be commercialized relatively quickly and add to bottom line in a few months.

That is what I see and would like hearing others opinions.